Document is current
Any future updates will be listed below
-
Authors
Song, Seulki
Koh, Youngil
Kim, Seokhyeon
Lee, Sang Mi
Kim, Hyun Uk
Ko, Jung Min
Lee, Se-Hoon
Yoon, Sung-Soo
Park, Solip http://orcid.org/0000-0002-5988-5339
-
Funding
Funding for this research was provided by:
Agencia Estatal de Investigación (PID2019-109571RA-I00)
Spanish National Plan for Scientific and Technical Research and Innovation
Centro de Biología Molecular Severo Ochoa
Korea Health Industry Development Institute (HI18C1876)
National Research Foundation of Korea (2021R1A2C3005360)
College of Medicine, Seoul National University (1120190020)
Seoul National University Hospital (03-2020-0380)
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 30 October 2023
First Online: 25 December 2023
Declarations
:
: This paper reanalyzes previously published data sets. Sequencing of human subjects’ tissue was performed by PCAWG and TCGA consortium members under approval of Seoul National University Hospital Review Boards (IRBs; H-1201–099-396). 30 samples for the metabolic profiles (8 PAH heterozygote carriers and 22 healthy controls) were recruited from the Seoul National University Hospital. All participants provided written informed consent for study participation, and they were approved by the Seoul National University Hospital (IRB No. H-2101–196-1193). 245 PBMC specimens from Korean patients with lung squamous cell carcinoma were recruited from the Samsung Medical Center (SMC). All participants provided written informed consent for study participation under the IRB No. 2013–10-112 and 2008–06-033.
: Not applicable.
: The authors declare that they have no competing interests.
